Article Type
Changed
Thu, 12/06/2018 - 17:04
Display Headline
VIDEO: Providers should include drospirenone in their arsenal of OC options

PHILADELPHIA – Despite recent controversy over the risk of venous thromboembolism in users of combination contraceptive pills containing drospirenone, Dr. Jennifer Dietrich, associate professor of obstetrics and gynecology at Baylor College of Medicine, Houston, urges providers to carefully weigh the associated risks and benefits against the threat of an unwanted pregnancy when prescribing to adolescents.

"Counsel your patient carefully, and help them choose the right method," Dr. Dietrich said at the annual meeting of the North American Society for Pediatric and Adolescent Gynecology. "Even when it includes drospirenone."

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

[email protected]

On Twitter @whitneymcknight

Author and Disclosure Information

Publications
Topics
Legacy Keywords
venous thromboembolism, contraceptive pill, drospirenone, Dr. Jennifer Dietrich,
Author and Disclosure Information

Author and Disclosure Information

PHILADELPHIA – Despite recent controversy over the risk of venous thromboembolism in users of combination contraceptive pills containing drospirenone, Dr. Jennifer Dietrich, associate professor of obstetrics and gynecology at Baylor College of Medicine, Houston, urges providers to carefully weigh the associated risks and benefits against the threat of an unwanted pregnancy when prescribing to adolescents.

"Counsel your patient carefully, and help them choose the right method," Dr. Dietrich said at the annual meeting of the North American Society for Pediatric and Adolescent Gynecology. "Even when it includes drospirenone."

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

[email protected]

On Twitter @whitneymcknight

PHILADELPHIA – Despite recent controversy over the risk of venous thromboembolism in users of combination contraceptive pills containing drospirenone, Dr. Jennifer Dietrich, associate professor of obstetrics and gynecology at Baylor College of Medicine, Houston, urges providers to carefully weigh the associated risks and benefits against the threat of an unwanted pregnancy when prescribing to adolescents.

"Counsel your patient carefully, and help them choose the right method," Dr. Dietrich said at the annual meeting of the North American Society for Pediatric and Adolescent Gynecology. "Even when it includes drospirenone."

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

[email protected]

On Twitter @whitneymcknight

Publications
Publications
Topics
Article Type
Display Headline
VIDEO: Providers should include drospirenone in their arsenal of OC options
Display Headline
VIDEO: Providers should include drospirenone in their arsenal of OC options
Legacy Keywords
venous thromboembolism, contraceptive pill, drospirenone, Dr. Jennifer Dietrich,
Legacy Keywords
venous thromboembolism, contraceptive pill, drospirenone, Dr. Jennifer Dietrich,
Article Source

EXPERT ANALYSIS FROM NASPAG ANNUAL MEETING

PURLs Copyright

Inside the Article